EDGAR Filing Documents for 9999999995-18-002640

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-18-002640

Accepted

2018-10-18 00:15:26

Documents

Effectiveness Date

2018-10-17

Registration Form

POS AM

Reference AccNo

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	601
	Complete submission text file	9999999995-18-002640.txt		1707

Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3

Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)